[EN] PHOSPHOHALOHYDRINS, METHOD FOR MAKING SAME AND USES<br/>[FR] PHOSPHOHALOHYDRINES, PROCEDE DE FABRICATION ET APPLICATIONS
申请人:INST NAT SANTE RECH MED
公开号:WO2000012516A1
公开(公告)日:2000-03-09
L'invention concerne des composés comprenant au moins un groupement phosphohalohydrine de formule (1), où X est un halogène choisi parmi I, Br, Cl, R1 est choisi parmi -CH3 et -CH2-CH3, Cat+ est un cation organique ou minéral, et n est un nombre entier compris entre 2 et 20, leurs procédés de préparation et leurs applications, notamment thérapeutiques et pour activer les lymphocytes Tη9δ2 des primates.
Phosphohalohydrins, process for the production thereof and use thereof
申请人:INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICATE
公开号:US20040087555A1
公开(公告)日:2004-05-06
The invention provides compounds comprising at least one phosphohalohydrin group of the formula:
1
where X is a halogen selected from among I, Br, Cl,
R1 is selected from among —CH
3
and —CH
2
—CH
3
,
Cat+ is an organic or inorganic cation,
and n is an integer between 2 and 20,
processes for the production thereof and uses thereof, in particular therapeutic uses and for activating primate T&ggr;9&dgr;2 lymphocytes.
Methods of Using Phosphoantigen for the Treatment of Cancer
申请人:Tiollier Jérôme
公开号:US20100029674A1
公开(公告)日:2010-02-04
The present invention relates to compositions and methods useful for treating a cancer in mammals, including humans. The methods and compositions typically comprise use of a chemotherapeutic agent and a γδ T cell activator such that the composition is effective for treating a cancer. Preferably the composition enhances the effect of the γδ T cell activator and/or prevents or delays the escape of a tumor from control chemotherapy, particularly an anti-angiogenic chemotherapeutic agent.
Phosphohalohydrins, Process For The Production Thereof And Use Thereof
申请人:Belmant Christian
公开号:US20100068179A1
公开(公告)日:2010-03-18
The invention provides compounds comprising at least one phosphohalohydrin group of the formula:
where X is a halogen selected from among I, Br, Cl,
R1 is selected from among —CH
3
and —CH
2
—CH
3
,
Cat+ is an organic or inorganic cation,
and n is an integer between 2 and 20,
processes for the production thereof and uses theroef, in particular therapeutic uses and for activating primate Tγ9δ2 lymphocytes.
METHOD FOR PRODUCING GAMMA DELTA T CELL POPULATION
申请人:Ideno Mitsuko
公开号:US20110158954A1
公开(公告)日:2011-06-30
A method for preparing a γδ T cell population, characterized in that the method includes the step of culturing a cell population containing γδ T cells, in the presence of (a) fibronectin, a fibronectin fragment or a mixture thereof and (b) an activating factor of γδ T cells. According to the present invention, a method for preparing a γδ T cell population is provided. The γδ T cell population obtained by the method is suitably used in, for example, immunotherapy. Therefore, the method of the present invention is expected to greatly contribute to a medical field.